EY Global Life Sciences Center announces new appointments to its leadership team
Boston, 9 January 2014
The EY Global Life Sciences Center today announced several new appointments, including global leaders for each of the four EY service lines, Assurance, Tax, Transaction and Advisory services.
As part of these new appointments, the Global Life Sciences Center also announced that John Celentano has been named a Senior Advisor for the Center. Mr. Celentano’s over 30-year career includes extensive leadership experience in a variety of functions at Bristol-Myers Squibb, including as President of its Healthcare Group, which included the non-pharmaceutical businesses Mead Johnson Nutrition, ConvaTec and Medical Imaging. In this role, Mr. Celentano led the successful IPO of Mead Johnson and the spin out and sale of ConvaTec. In his new position advising EY, Mr. Celentano will draw on his broad industry experience to advise EY member firm clients and sector teams on a variety of strategic and transformational business issues.
The Global Life Sciences Center also announced today the appointment of the following global service line leaders:
- Scott Bruns will continue his role of Global Life Sciences Assurance Services Leader. Mr. Bruns has advised a range of global public and private clients, with particular expertise in technical accounting issues in the pharmaceutical, medical device and biotechnology industries. In particular, Scott has significant experience with US SEC and international financial reporting standards, and assisting companies in the structuring and execution of public offerings, acquisitions, equity investments and joint ventures.
- Mitchell Cohen has been named Global Life Sciences Tax Services Leader. Mr. Cohen’s extensive experience serving life sciences companies includes corporate and partnership taxation, transaction tax strategy and planning, tax risk and compliance and research tax credits, as well as the tax processes, systems and accounting methods specific to the pharmaceutical, biotechnology and medical device industries. Mr. Cohen also presently serves as tax coordinating partner for several leading global pharmaceutical clients of Ernst & Young LLP in the US.
- Jeffrey Greene will continue to serve as Global Life Sciences Transactions Advisory Services Leader, supporting EY firm clients on a variety of divestitures, acquisitions, financings and restructurings. A highly-knowledgeable advisor in the areas of strategic valuation, portfolio management, solvency, and performance measurement, Mr. Greene’s prior roles include EY Global Vice Chair—Corporate Finance, Director, Corporate Finance and Valuation for Ernst & Young LLP, and EY Americas Markets Leader for Divestitures.
- Kimberly Ramko has been appointed Global Life Science Advisory Services Leader. In this role Ms. Ramko will focus on service innovation, alliance management, and helping to implement large, complex business transformations. Kim will continue in her role as EY Americas Advisory Life Sciences Industry Sector Leader. Ms. Ramko has extensive consulting experience with life sciences companies focused in the areas of business intelligence and analytics, health informatics, commercial operations and master data management.
“I am thrilled to announce this new investment in talent and leadership for the Global Life Sciences Center, which builds upon our existing strengths and the exceptional professionals serving our clients today,” said Glen Giovannetti, EY Global Life Sciences Leader. “Life sciences companies continue to face an increasingly complex business environment as they seek new sources of growth and ways to enhance operating efficiency. We are excited about the breadth of experience that John, Scott, Kim, Mitch and Jeff bring to help our clients meet the challenges ahead.”
Notes to Editors
How EY’s Global Life Sciences Center can help your business
Life sciences companies — from emerging to multinational — are facing challenging times as access to health care takes on new importance. Stakeholder expectations are shifting, the costs and risks of product development are increasing, alternative business models are manifesting, and collaborations are becoming more complex. At the same time, players from other sectors are entering the field, contributing to a new ecosystem for delivering health care. New measures of success are also emerging as the sector begins to focus on improving a patient's “health outcome,” and not just on units of a product sold. Our Global Life Sciences Center brings together a worldwide network of more than 7,000 sector-focused assurance, tax, transaction and advisory professionals to anticipate trends, identify implications and develop points of view on how to respond to the critical sector issues. We can help you navigate your way forward and achieve success in the new health ecosystem. For more information about the Global Life Sciences Center, as well as our industry insights, perspectives and thought leadership, please visit us at ey.com/lifesciences and lifesciencesblog.ey.com. We are also on Twitter @EY_LifeSciences.
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Ernst & Young LLP is a member firm serving clients in the US. For more information about our organization, please visit ey.com.